As we develop new processes and evaluate new technologies it is important to consider sustainability and the environmental impact and how this can be improved. It is an area that we have been actively considering since the early days of BioSolve Process; when the focus
World-class bioprocess modelling software developer unveils new customisable features for users. LONDON, 11 December 2019 – Biopharm Services, the bioprocess analysis software developer, today announced the release of the latest version of its flagship process analysis and economic modelling tool, BioSolve Process. BioSolve Process 8
The BioSolve User forum was held in the historic town of Leiden; we welcomed over 20 attendees. We met together for a in-depth review of new features, and to learn from and interact with other users in the expanding community. A major theme of the
1. General questions What is your name, organization name and position? Magnus Bergman, Senior research engineer at the R&D department at Cytiva Would you classify yourself as a beginner, intermediate user or power user of BioSolve Process? Intermediate or power user. Which version of BioSolve
This is the exact question we asked an audience in a session led by our Sales & Marketing Director Dr Yuki Abe, alongside GE Healthcare’s Jonathan Royce at our User Group Forum back in April 2018. By using the power of real time polling, we
General questions What is your name, organization name and position? Steve Jones, BioPhorum Operations Group, Director and Phorum Lead of Technology Roadmapping What does your organization do? Our mission is to create an environment where the global biopharmaceutical industry can collaborate and accelerate their rate
Held in April at le Meriden Cambridge MA, Now in its 10th year the forum ably illustrated the applicability of BioSolve Process to a wide range of challenges we face in bioprocessing. It was pleasing to see representatives from the Biopharm supply chain; from academics,
General questions What is your name, company name and position? My name is Karol Lacki and I’m Vice President of Technology Development at Avitide. At Avitide we develop and manufacture custom affinity resins. Would you classify yourself as a beginner, intermediate, or expert user of
General questions What is your name, company name and position? My name is Alfred Luitjens, I currently work as Director of Cell Technologies at Batavia Biosciences, a CDMO with extensive experience in vaccine, recombinant protein, monoclonal antibody and gene therapy projects. What is involved in
This week we announced that we have supported the BioPhorum Operations Group in the development of the first edition of The Technology Roadmap for the Biopharmaceutical Manufacturing Industry. So why did we get involved? As we all know, current trends in the biopharmaceutical industry, including
